AMRI’s subsidiary, Albany Molecular Research (UK) Ltd., has been awarded a seven-year government contract for the development and manufacture of an active ingredient for clinical trials. The contract was awarded by the Defense Science and Technology Laboratory (Dstl), acting on behalf of the UK’s Secretary of State for Defence, the Department of National Defence of Canada and Minister of Defence of the Kingdom of the Netherlands.   AMRI will provide development and scale-up of the investig...